The use of antipsychotics in young children is declining but doctors continue to prescribe these medications off-label for conditions not approved by the Food and Drug Administration and without the recommended psychiatric consultation, a Rutgers study found. The study, published in the Journal of the American Academy of Child and Adolescent Psychiatry, looked at 301,311 antipsychotic prescriptions filled by privately insured children ages 2 to 7 in the United States from 2007 to 2017. While results are encouraging that antipsychotic prescribing declined in recent years, the researchers noted that they continued to be prescribed for conditions lacking safety and effectiveness data such as conduct disorder, ADHD, anxiety and depression. 
Read More

Pin It on Pinterest

Share This

Share This!

Share this post now with your friends.